Skip to main content
. 2023;24(5):1725–1730. doi: 10.31557/APJCP.2023.24.5.1725

Table 2.

Analysis of EpCAM, CK18, and CK19 and CA15.3 in All Studied Groups

Parameter Control Non metastatic Metastatic P value
CK18 (%) 11.3+6.5 27.1+15.2 66.53+19.1 P< 0.0001
CK19 (%) 9.2+3.9 22.2+14.7 56.2+27.6 P< 0.0001
CA15.3 (mg/dL) 7.5 +1.3 37.2+11.7 82.3+15.7 P< 0.0001

Data are expressed as mean+ SD.